Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukun He

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|January 23, 2024
Lysophosphatidylcholine acyltransferase level predicts the severity and prognosis of patients with community-acquired pneumonia: a prospective multicenter studyLi Chen, Jianbo Xue, Lili Zhao, et al.
Clinical Immunology (Orlando, Fla.)|January 16, 2023
Metabolic landscape dysregulation in bronchoalveolar lavage fluid of checkpoint inhibitor pneumonitisWenyi Yu, Yukun He, Ying Shang, et al.
Clinical Immunology (Orlando, Fla.)|March 2, 2023
Corrigendum to "Metabolic landscape dysregulation in bronchoalveolar lavage fluid of checkpoint inhibitor pneumonitis" [Clinical Immunology 247 (2023) 109230]Wenyi Yu, Yukun He, Ying Shang, et al.
Ebiomedicine|August 4, 2024
The potential role of lung microbiota and lauroylcarnitine in T-cell activation associated with checkpoint inhibitor pneumonitisWenyi Yu, Keqiang Wang, Yukun He, et al.
Journal of Inflammation Research|January 20, 2022
Shared and Specific Lung Microbiota with Metabolic Profiles in Bronchoalveolar Lavage Fluid Between Infectious and Inflammatory Respiratory DiseasesYukun He, Wenyi Yu, Pu Ning, et al.
Applied and Environmental Microbiology|February 23, 2026
Global genomic landscape of <i>Staphylococcus lugdunensis</i>: population structure, antimicrobial resistance, and virulence determinantsDonghong Yang, Pengcheng Du, Fang Wang, et al.
Annals of Translational Medicine|May 9, 2022
Targeted lipidomics reveals phospholipids and lysophospholipids as biomarkers for evaluating community-acquired pneumoniaXinqian Ma, Li Chen, Yukun He, et al.
Proteomics. Clinical Applications|February 9, 2024
Plasma proteome analysis and validation of patients with community-acquired pneumonia: A cohort studyLili Zhao, Wenjie Bian, Ying Shang, et al.
Infection and Drug Resistance|February 20, 2026
Comparative Genomic Analysis of <i>Pseudomonas aeruginosa</i> Isolates from Community-Acquired and Hospital-Acquired PneumoniaFeifei Yang, Shukun Chai, Li Yan, et al.
Genomics, Proteomics & Bioinformatics|October 8, 2024
Enhancing Variant Calling in Whole-exome Sequencing Data Using Population-matched Reference GenomesShuming Guo, Zhuo Huang, Yanming Zhang, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|January 23, 2024
Lysophosphatidylcholine acyltransferase level predicts the severity and prognosis of patients with community-acquired pneumonia: a prospective multicenter studyLi Chen, Jianbo Xue, Lili Zhao, et al.
Clinical Immunology (Orlando, Fla.)|January 16, 2023
Metabolic landscape dysregulation in bronchoalveolar lavage fluid of checkpoint inhibitor pneumonitisWenyi Yu, Yukun He, Ying Shang, et al.
Clinical Immunology (Orlando, Fla.)|March 2, 2023
Corrigendum to "Metabolic landscape dysregulation in bronchoalveolar lavage fluid of checkpoint inhibitor pneumonitis" [Clinical Immunology 247 (2023) 109230]Wenyi Yu, Yukun He, Ying Shang, et al.
Ebiomedicine|August 4, 2024
The potential role of lung microbiota and lauroylcarnitine in T-cell activation associated with checkpoint inhibitor pneumonitisWenyi Yu, Keqiang Wang, Yukun He, et al.
Journal of Inflammation Research|January 20, 2022
Shared and Specific Lung Microbiota with Metabolic Profiles in Bronchoalveolar Lavage Fluid Between Infectious and Inflammatory Respiratory DiseasesYukun He, Wenyi Yu, Pu Ning, et al.
Applied and Environmental Microbiology|February 23, 2026
Global genomic landscape of <i>Staphylococcus lugdunensis</i>: population structure, antimicrobial resistance, and virulence determinantsDonghong Yang, Pengcheng Du, Fang Wang, et al.
Annals of Translational Medicine|May 9, 2022
Targeted lipidomics reveals phospholipids and lysophospholipids as biomarkers for evaluating community-acquired pneumoniaXinqian Ma, Li Chen, Yukun He, et al.
Proteomics. Clinical Applications|February 9, 2024
Plasma proteome analysis and validation of patients with community-acquired pneumonia: A cohort studyLili Zhao, Wenjie Bian, Ying Shang, et al.
Infection and Drug Resistance|February 20, 2026
Comparative Genomic Analysis of <i>Pseudomonas aeruginosa</i> Isolates from Community-Acquired and Hospital-Acquired PneumoniaFeifei Yang, Shukun Chai, Li Yan, et al.
Genomics, Proteomics & Bioinformatics|October 8, 2024
Enhancing Variant Calling in Whole-exome Sequencing Data Using Population-matched Reference GenomesShuming Guo, Zhuo Huang, Yanming Zhang, et al.
Pageof 7